share_log

苑东生物(688513.SH)新增认定李竹石为核心技术人员

Chengdu Easton Biopharmaceuticals (688513.SH) has newly recognized Li Zhushi as a core technical personnel.

Zhitong Finance ·  Jun 28 07:42

Chengdu Easton Biopharmaceuticals (688513.SH) announced that the company's deputy general manager and core technical staff HONG CHEN...

According to an announcement by Chengdu Easton Biopharmaceuticals (688513.SH), the company's deputy general manager and core technical staff HONG CHEN has reached the statutory retirement age and resigned from the position for personal reasons, no longer holding any position in the company.

On June 28, 2024, the Board of Directors' 20th meeting of the third session of Chengdu Easton Biopharmaceuticals approved the proposal of "adding recognized core technical staff", recognizing LIZHUSHI as the company's core technical staff.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment